DrugPatentWatch Database Preview
Methylprednisolone sodium succinate - Generic Drug Details
What are the generic sources for methylprednisolone sodium succinate and what is the scope of freedom to operate?
Methylprednisolone sodium succinate
is the generic ingredient in four branded drugs marketed by Abbott, Hospira, Hospira Inc, Elkins Sinn, Organon Usa Inc, Abraxis Pharm, Amneal, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, Sagent Pharms Inc, Teva Parenteral, Watson Labs, and Pharmacia And Upjohn, and is included in forty-seven NDAs. Additional information is available in the individual branded drug profile pages.There are forty drug master file entries for methylprednisolone sodium succinate.
Summary for methylprednisolone sodium succinate
| US Patents: | 0 |
| Tradenames: | 4 |
| Applicants: | 16 |
| NDAs: | 47 |
| Drug Master File Entries: | 40 |
| Bulk Api Vendors: | 74 |
| Clinical Trials: | 16 |
| Patent Applications: | 4,307 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | methylprednisolone sodium succinate at DailyMed |
Recent Clinical Trials for methylprednisolone sodium succinate
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Louisiana State University Health Sciences Center in New Orleans | Phase 1/Phase 2 |
| Children's Hospital of Fudan University | Phase 3 |
| Taipei Medical University WanFang Hospital | Phase 2/Phase 3 |
Synonyms for methylprednisolone sodium succinate
| 11-beta,17,21-Trihydroxy-6-alpha-methyl-1,4-pregnadiene-3,20-dione 21-(sodium succinate) |
| 11beta,17,21-Trihydroxy-6alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl 3-carboxypropionate |
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) |
| 11beta,17,21-Trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione 21-(sodium succinate) |
| 11ss,17,21-trihydroxy-6a-methylpregna-1,4-diene-3,20-dione 21-(hydrogen succinate) |
| 2375-03-3 |
| 2921-57-5 |
| 375M033 |
| 4-(2-((6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl)-2-oxoethoxy)-4-oxobutanoic acid |
| 4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoic acid |
| 4-oxidanylidene-4-[2-oxidanylidene-2-[(6S,8S,9S,10R,11S,13S,14S,17R)-6,10,13-trimethyl-11,17-bis(oxidanyl)-3-oxidanylidene-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]ethoxy]butanoic acid |
| 5GMR90S4KN |
| 6-alpha-Methylprednisolone sodium succinate |
| 6-Methylprednisolone 21-hemisuccinate sodium salt |
| 6.alpha.-Methylprednisolone 21-hemisuccinate sodium salt |
| 6.alpha.-Methylprednisolone 21-sodium hemisuccinate |
| 6.alpha.-Methylprednisolone 21-sodium succinate |
| 6.alpha.-Methylprednisolone sodium hemisuccinate |
| 6.alpha.-Methylprednisolone sodium succinate |
| 6.alpha.-Methylpregnisolone 21-sodium succinate |
| 6|A-Methylprednisolone 21-hemisuccinate (sodium salt) |
| 6|A-Methylprednisolone 21-hemisuccinate Sodium |
| 6A-methylprednisolone 21-hemisuccinate*sodium |
| 6AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade mark?-Methylprednisolone 21-hemisuccinate (sodium salt) |
| 6alpha-Methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione 21-hemisuccinate |
| 6alpha-Methylprednisolone 21-hemisuccinate |
| 6alpha-Methylprednisolone 21-hemisuccinate sodium salt |
| 6alpha-Methylprednisolone 21-hemisuccinate sodium salt, lyophilized powder |
| 6alpha-Methylprednisolone 21-sodium hemisuccinate |
| 6alpha-Methylprednisolone 21-sodium succinate |
| 6alpha-Methylprednisolone hemisuccinate |
| 6alpha-Methylprednisolone sodium hemisuccinate |
| 6alpha-Methylprednisolone sodium succinate |
| 6alpha-Methylpregnisolone 21-sodium succinate |
| 921M575 |
| A-methapred (TN) |
| A819819 |
| AK-94859 |
| AKOS015894899 |
| AKOS015962276 |
| AS-74917 |
| Asmacortone |
| C-22742 |
| C26H33O8.Na |
| C26H34O8 |
| CAS-2375-03-3 |
| CHEBI:135765 |
| CHEBI:6890 |
| CHEMBL1201081 |
| CHEMBL1201265 |
| Corticel |
| Cryosolona |
| Cryosolona [inj.] |
| CS-4582 |
| CS-8183 |
| CTK8G1090 |
| D00751 |
| D05000 |
| DB14644 |
| DSSTox_CID_3303 |
| DSSTox_GSID_23303 |
| DSSTox_RID_76967 |
| DTXSID2023303 |
| DTXSID80183466 |
| EC 220-863-9 |
| EINECS 219-156-8 |
| EINECS 220-863-9 |
| Emmetipi |
| Firmacort Fiale |
| FQISKWAFAHGMGT-SGJOWKDISA-M |
| HY-B1060 |
| HY-B1900 |
| I038 |
| LEC9GKY20K |
| Lemod Solu |
| LS-118430 |
| LS-118507 |
| M-6-P |
| Medrate [inj.] |
| Meghylprednisolone hemisuccinate |
| Methylprednisolone 21-(hydrogen succinate) |
| METHYLPREDNISOLONE HEMISUCCINATE |
| Methylprednisolone hemisuccinate (USP) |
| Methylprednisolone Hemisuccinate [USP] |
| Methylprednisolone Hemisuccinate Monosodium Salt |
| Methylprednisolone hydrogen hemisuccinate |
| Methylprednisolone hydrogen succinate |
| Methylprednisolone Hydrogen Succinate Sodium Salt |
| Methylprednisolone sodium hemisuccinate |
| Methylprednisolone sodium succinate (JAN/USP) |
| Methylprednisolone Sodium Succinate (methylprednisolone 21-(hydrogen succinate)) |
| Methylprednisolone Sodium Succinate [USAN:JAN] |
| Methylprednisolone sodium succinate [USP:JAN] |
| Methylprednisolone succinate |
| Methylprednisolone succinate (JP17) |
| Methylprednisolone succinate sodium salt |
| Metypred |
| Metypred [inj.] |
| Metypresol |
| MFCD00152612 |
| NCGC00185763-01 |
| Nirypan solubile |
| NSC 48989 |
| NSC-48989 |
| NSC48989 |
| Omnacortil |
| Prednilem |
| Prednisolone, 6alpha-methyl-, succinate, sodium salt |
| Prednisolone, succinate, sodium salt |
| Prednol |
| Prednol [inj.] |
| Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-6.alpha.-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6.alpha.,11.beta.)- |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21- (hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11-beta,17,21-trihydroxy-6-alpha-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt |
| Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-6alpha-methyl-, 21-(hydrogen succinate), monosodium salt (8CI) |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, (6alpha,11beta)- |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodium salt, (6alpha,11beta)- |
| Pregna-1,4-diene-3,20-dione, 21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-,(6-alpha,11-beta)- |
| Pregna-1,4-diene-3,20-dione,21-(3-carboxy-1-oxopropoxy)-11,17-dihydroxy-6-methyl-, monosodiumsalt, (6a,11b)- |
| Q27262132 |
| Q27282942 |
| s6588 |
| s6593 |
| SCHEMBL40947 |
| SCHEMBL7915 |
| sodium 4-{[(6alpha,11beta)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate |
| sodium 4-{2-[(1R,3aS,3bS,5S,9aR,9bS,10S,11aS)-1,10-dihydroxy-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]-2-oxoethoxy}-4-oxobutanoate |
| Sodium methylprednisolone succinate |
| sodium;4-[2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy]-4-oxobutanoate |
| Sol Melcort |
| Solu Medrol |
| Solu-Medrol |
| Solu-medrol (TN) |
| Solu-Medrone |
| Solumedrol |
| Succinic acid, 21-monoester with 11beta,17,21-trihydroxy-6alpha-methylpregna-1,4-diene-3,20-dione, monosodium salt |
| Tox21_113527 |
| U 9088 |
| Ubrason solubile |
| Ubrason solubile [inj.] |
| UNII-5GMR90S4KN |
| UNII-LEC9GKY20K |
| Urabason |
| Urbason solubile |
| Urbason-Soluble |
| W-107376 |
| ZINC3977781 |
US Patents and Regulatory Information for methylprednisolone sodium succinate
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospira Inc | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 040827-001 | Nov 25, 2008 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Aurobindo Pharma Ltd | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 207667-001 | Dec 15, 2015 | AP | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| Organon Usa Inc | METHYLPREDNISOLONE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 087535-001 | Jun 25, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Abraxis Pharm | METHYLPREDNISOLONE SODIUM SUCCINATE | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 088678-001 | Jun 8, 1984 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| Hospira | A-METHAPRED | methylprednisolone sodium succinate | INJECTABLE;INJECTION | 085854-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
